Background: Expenditure on systemic therapy for cancer has been increasing quickly owing
to population growth, increased use, both in the number of users and in prescription volume …

Purpose Factors likely to influence drug expenditures, drug expenditure trends in 2012, and
projected drug expenditures for US nonfederal hospitals and clinics in 2013 are discussed …

Objectives Some targeted therapies have improved survival and overall quality of cancer
care generally, but these increasingly expensive medicines have led to increases in …

PURPOSE: Drug cost is a significant factor in the ever-increasing expenditures for cancer
health care. METHODS: We used Medicare Part D administrative data to explore prescribing …

BACKGROUND To the authors' knowledge, no analysis has examined the specific
components of drug spending for overall cancer care. The authors' objective was to quantify …

Purpose Historical trends and factors likely to influence future pharmaceutical expenditures
are discussed, and projections are made for drug spending in 2019 in nonfederal hospitals …

Background Modern drug therapy accounts for a major share of health expenditure and
challenges public provider resources. The objective of our study was to compare drug …

Region Cancer Care Report, 2011–2012 Edition. 1 Prostate cancer patients and colorectal
cancer patients were slightly more likely to be seen in physicians' offices. Average charges …

Purpose: Recent cancer drug approvals are lauded as being more effective with relatively
fewer adverse effects, but these treatments come with a great cost to the US health care …

Purpose Historical trends and factors likely to influence future pharmaceutical expenditures
are discussed, and projections are made for drug spending in 2016 in nonfederal hospitals …